Invention Grant
- Patent Title: Human therapeutic targets and modulators thereof
-
Application No.: US16646978Application Date: 2018-09-14
-
Publication No.: US11749375B2Publication Date: 2023-09-05
- Inventor: John Baxter Biggins , Brian Roger Bowman , Gregory L. Verdine
- Applicant: LIFEMINE THERAPEUTICS, INC.
- Applicant Address: US MA Cambridge
- Assignee: LIFEMINE THERAPEUTICS, INC.
- Current Assignee: LIFEMINE THERAPEUTICS, INC.
- Current Assignee Address: US MA Cambridge
- Agency: MORRISON & FOERSTER LLP
- International Application: PCT/US2018/051134 2018.09.14
- International Announcement: WO2019/055816A 2019.03.21
- Date entered country: 2020-03-12
- Main IPC: G16B20/00
- IPC: G16B20/00 ; G16B35/10

Abstract:
Among other things, the present disclosure provides technologies for efficient and effective identification of ETaGs, for example, from fungi genomes. In some embodiments, provided technologies are particularly useful for identifying mammalian targets of biosynthetic products of fungi. In some embodiments, provided technologies are particularly useful for identifying and/or prioritizing human targets for drug development. In some embodiments, provided technologies are particularly useful for developing modulators for human targets based on biosynthetic products of fungi.
Public/Granted literature
- US20200211673A1 HUMAN THERAPEUTIC TARGETS AND MODULATORS THEREOF Public/Granted day:2020-07-02
Information query